Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

8.02
Delayed Data
As of Aug 24
 -0.20 / -2.43%
Today’s Change
5.26
Today|||52-Week Range
9.54
+1.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues25.1M27.3M59.7M63.1M
 
 
 
 
 
Cost of Goods Sold12.2M13.3M28.9M30.8M
 
 
 
 
 
Depreciation And Amortization1.8M1.9M5.6M5.4M
 
 
 
 
 
 
Operating ExpensesGross Income11.1M12.1M25.1M27.0M
 
 
 
 
 
General Expenses11.0M17.3M23.2M24.8M
 
 
 
 
 
Research And Development815.0K1.8M1.3M1.3M
 
 
 
 
 
Total Operating Expenses25.0M32.5M57.8M60.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income114.0K-5.2M1.9M2.2M
 
 
 
 
 
Interest Expense On Debt239.0K232.0K1.6M1.4M
 
 
 
 
 
Other Expenses0.002.0M0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-125.0K-3.4M329.0K745.0K
 
 
 
 
 
Income Taxes0.00-2.0M-174.0K-332.0K
 
 
 
 
Preferred Dividend0.00-122.0K-5.6M-5.6M
 
 
 
 
Net Income-125.0K-1.5M155.0K413.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS60.5M60.9M76.1M77.4M
 
 
 
 
 
Shares To Calculate EPS Diluted60.5M60.9M76.1M77.4M
 
 
 
 
 
 
Earnings Per ShareEPS$0.00-$0.03-$0.07-$0.07
 
 
 
 
EPS Diluted-$0.00-$0.03-$0.07-$0.07